Latest Headlines
-
Agilent Accelerates Digital Pathology With The Launch Of The Agilent S540MD Slide Scanner System
1/23/2026
Agilent Technologies Inc. today announced the launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, available for sale in key European markets.
-
Ozelle Brings AI-Powered, Scenario-Ready Diagnostics To WHX Labs Dubai 2026
1/23/2026
Ozelle, a global innovator in intelligent diagnostics, will showcase its next-generation solution at WHX Labs Dubai 2026 (Feb 10–13, Booth S1.D58).
-
BD Helps Scientists Advance Immunology And Cancer Research With AI-Powered Insights And Automation
1/23/2026
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of BD® Research Cloud 7.0, furthering the company's AI roadmap while strengthening its leadership in flow cytometry and life sciences research.
-
Pangea Laboratory And Gene Solutions Establish Strategic Collaboration To Advance Cancer Diagnostics In The United States
1/21/2026
Pangea Laboratory, a CLIA-certified, CAP-accredited leader in Next-Generation Sequencing (NGS) and molecular diagnostic validation and innovation, today announced a strategic collaboration with Gene Solutions, a global biotechnology company, to validate AI-driven liquid biopsy assays for use in cancer detection, characterization, and monitoring within CLIA/CAP laboratory settings in the U.S. market.
-
Zepto Life Technology Launches Plasma-Based FungiFlex® Mold Panel As CLIA Reference Laboratory Test
1/21/2026
Zepto Life Technology has announced the launch of the FungiFlex® Mold Panel, a plasma-based molecular diagnostic test now available through its CLIA-certified reference laboratory, expanding access to faster, noninvasive testing for patients at risk of invasive fungal infections (IFIs).
-
Sysmex America Expands CN-Series With CN-9000 To Help Labs Of All Sizes Optimize Workflow
1/21/2026
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, today announced the newest addition to its CN-Series, the CN-9000 Automated Hemostasis Solution.
-
Cepheid Receives FDA Clearance For Xpert® GI Panel To Support Broad Detection Of Gastrointestinal Pathogens
1/20/2026
Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast and accurate detection of 11 clinically relevant gastrointestinal (GI) pathogens from a single patient sample.
-
Cytespace Africa Labs Expands Molecular Testing Capacity To Advance Clinical Trials Across Sub-Saharan Africa
1/20/2026
Cytespace Africa Laboratories (Cytespace), an MLM Medical Labs company and the only fully CAP-accredited central laboratory in South Africa, has significantly expanded its molecular testing capabilities to meet rising demand across Sub-Saharan Africa.
-
NeuroQure Launches First-Ever Functional Biophysical Marker Test For Autism, Transforming Early Autism Risk Diagnosis
1/20/2026
NeuroQure, a pioneering leader in neurological diagnostics, announces the launch of ASD Insight, a first-of-its-kind test designed to identify autism risk as early as birth.
-
Instrument Manager™ v9.01 Brings New Features And Improved Security To Clinical Laboratories
1/15/2026
Data Innovations® (DI), the healthcare industry's leading laboratory middleware provider, has released Instrument Manager™ (IM) v9.01.